A Luminex Assay Detects Amyloid β Oligomers in Alzheimer’s Disease Cerebrospinal Fluid

• Adrianna Z. Herskovits ,

  * E-mail: azherskovits@partners.org

  Affiliations Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Neurology, Massachusetts General Hospital, Mass General Institute for Neurodegenerative Disease, Charlestown, Massachusetts, United States of America

  ⨯
• Joseph J. Locascio,

  Affiliation Massachusetts General Hospital, Memory and Movement Disorders Units Alzheimer’s Disease Research Center, Boston, Massachusetts, United States of America

  ⨯
• Elaine R. Peskind,

  Affiliations Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington, United States of America, Mental Illness Research and Education Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, United States of America

  ⨯
• Ge Li,

  Affiliation Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯
• Bradley T. Hyman

  Affiliation Department of Neurology, Massachusetts General Hospital, Mass General Institute for Neurodegenerative Disease, Charlestown, Massachusetts, United States of America

  ⨯